Cargando…
Silver Nanoparticles Selectively Treat Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors in a Neurofibromin-Dependent Manner
Neurofibromatosis type 1 (NF1) is among the most common neurogenic disorders, characterized by loss of function mutations in the neurofibromin gene (NF1). NF1 patients are extremely susceptible to developing neurofibromas, which can transform into deadly malignant peripheral nerve sheath tumors (MPN...
Autores principales: | Alewine, Garrett, Knight, Jerrica, Ghantae, Adithya, Mamrega, Christina, Attiah, Bashnona, Coover, Robert A., Fahrenholtz, Cale D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321475/ https://www.ncbi.nlm.nih.gov/pubmed/35887576 http://dx.doi.org/10.3390/jpm12071080 |
Ejemplares similares
-
Neurofibromin level directs RAS pathway signaling and mediates sensitivity to targeted agents in malignant peripheral nerve sheath tumors
por: Kahen, Elliot John, et al.
Publicado: (2018) -
Malignant Peripheral Nerve Sheath Tumor Arising from Neurofibromatosis
por: Lee, Dae-Sung, et al.
Publicado: (2013) -
Malignant Peripheral Nerve Sheath Tumors in Children with Neurofibromatosis Type 1
por: Pourtsidis, Apostolos, et al.
Publicado: (2014) -
Neurofibromin haploinsufficiency results in altered spermatogenesis in a mouse model of neurofibromatosis type 1
por: Chohan, Harleen, et al.
Publicado: (2018) -
Malignant peripheral nerve sheath tumour in a patient with a plexiform neurofibromatosis
por: Nekkanti, Ravi, et al.
Publicado: (2015)